Ibnsina Pharma (CAI:ISPH) YoY EBITDA Growth : 72.96% (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Ibnsina Pharma YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Ibnsina Pharma's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 72.96%.

Ibnsina Pharma's EBITDA per Share for the three months ended in Mar. 2025 was E£0.87.

Ibnsina Pharma YoY EBITDA Growth Historical Data

The historical data trend for Ibnsina Pharma's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibnsina Pharma YoY EBITDA Growth Chart

Ibnsina Pharma Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

-18.64

30.06

31.13

78.78

76.66

Ibnsina Pharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															53.82	70.19	79.34	99.00	72.96

Ibnsina Pharma YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Ibnsina Pharma's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(2.634	-	1.491)	/	\| 1.491 \|
=	76.66 %

Ibnsina Pharma's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(0.87	-	0.503)	/	\| 0.503 \|
=	72.96 %

Ibnsina Pharma YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Ibnsina Pharma's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Ibnsina Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ibnsina Pharma (CAI:ISPH) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

Industrial zone 1, PO box 91, Obour, EGY

Website

http://www.ibnsina-pharma.com

Ibnsina Pharma is an Egypt based pharmaceutical distribution company. It is engaged in purchasing and selling in wholesale and distribution of pharmaceutical, semi- pharmaceutical and cosmetic products. It distributes a portfolio of pharmaceutical products from local and multinational pharmaceutical companies to retail pharmacies, wholesalers, hospitals, and public health institutions. In addition, the company also offers services including warehousing and logistics, marketing solutions, importation, and packaging, market research, and analysis.

Ibnsina Pharma Headlines

No Headlines